The University of Cambridge is a collegiate research university in Cambridge, United Kingdom. Founded in 1209 and granted a royal charter by Henry III in 1231, Cambridge is the second-oldest university in the English-speaking world and the world's third-oldest surviving university.

During the past decade, University of Cambridge conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Cambridge" #1 sponsor was "University of Cambridge" with 17 trials, followed by "Rhythm Pharmaceuticals, Inc." with 2 trials sponsored, "Actelion" with 1 trials sponsored, "Becton, Dickinson and Company" with 1 trials sponsored and "CHDI Foundation, Inc." with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Cambridge" #1 collaborator was "Cambridge University Hospitals NHS Foundation Trust" with 10 trials as a collaborator, "The Leeds Teaching Hospitals NHS Trust" with 3 trials as a collaborator, "Wellcome Trust" with 3 trials as a collaborator, "Jaeb Center for Health Research" with 2 trials as a collaborator and "Juvenile Diabetes Research Foundation" with 2 trials as a collaborator. Other collaborators include 60 different institutions and companies that were collaborators in the rest 67 trials.

According to Clinical.Site data, the most researched conditions in "University of Cambridge" are "Diabetes Mellitus" (4 trials), "Diabetes Mellitus, Type 1" (4 trials), "Endocrine System Diseases" (4 trials), "Glucose Metabolism Disorders" (4 trials) and "Autoimmune Diseases" (3 trials). Many other conditions were trialed in "University of Cambridge" in a lesser frequency.

Most popular intervention types in "University of Cambridge" are "Drug" (13 trials), "Device" (6 trials), "Diagnostic Test" (6 trials), "Other" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "FlorenceM" (2 trials), "Setmelanotide" (2 trials), "68Ga-DOTATATE PET-MRI" (1 trials) and "7 Tesla Magnetic Resonance Imaging" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Cambridge" are 29 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Cambridge". undefined are not yet recruiting, 10 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in University of Cambridge, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Cambridge, 5 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 10 trials that are defined as “Not Applicable".

University of Cambridge has several departments that took part in Clinical trials: "University of Cambridge Cancer Research UK" - 10 trials, "MRC Cognition and Brain Sciences Unit" - 5 trials, "University of Cambridge; Department of Clinical Neurosciences" - 2 trials, "Addenbrookes Hospital; Cambridge Cancer Trials Centre, S4 Box 279" - 2 trials, "Cambridge Cancer Trials Centre, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital" - 2 trials, "University Department of Paediatrics" - 2 trials, "Clinical Pharmacology Unit, Box 110, Level 3 ACCI, Addenbrookes Hospital" - 2 trials